ReposiTrak offers a cash-rich, high-margin SaaS traceability platform whose near-term growth pause may be masking a powerful 2028 regulatory adoption cycle.
Overview
ReposiTrak is a profitable, cash-rich SaaS compliance platform temporarily slowed by the FSMA 204 deadline extension. Q3 FY2026 revenue was flat at $5.88 million, but operating income rose 24.5% as expenses fell, producing a 38.3% operating margin. More than 98% recurring revenue, preferred stock redemptions, buybacks, and a new SPAR strategic alliance support long-term EPS growth. The core debate is timing: delayed regulatory urgency versus durable food traceability demand.